Tyrosine kinase inhibitorPhase 3 trialInvestigational
Sorafenib
How it works
Blocks multiple tyrosine kinases involved in tumor growth and angiogenesis.
Cancer types
Lung Cancer— All patients
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Improving Sorafenib Delivery for Breast Cancer Treatment | Breast Cancer | lab-study | — | Source → |
| Testing Riluzole and Sorafenib in Advanced Solid Tumors and Melanoma | Melanoma | phase-1 | — | Source → |
| Testing Combination Therapy for Acute Myeloid Leukemia | Leukemia | phase-1 | — | Source → |
| Targeted Nanoparticles Deliver Cancer Drug More Effectively | Breast Cancer | animal-study | Treatment with the nanoparticles resulted in a 66.1% decrease in tumor volumes in mice. | Source → |
| Dammarolic Acid Enhances Lung Cancer Treatment | Lung Cancer | lab-study | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.